Patient Advocates
A patient-focused research model
At BioCanRx, we know that patient and caregiver voices improve research. By connecting researchers and patients through our Learning Institute and funding projects that improve the design of new therapies and inform the social and economic impacts of new therapies we promote patient partnerships as an essential part of the journey from the lab bench to the bedside and healthcare system.
Interested in joining our work as a patient or caregiver advocate?
Learn more about cancer immunotherapy, apply for the Learning Institute, or learn more about getting involved with cancer immunotherapy research.
What is Immunotherapy?
Stories from the Clinic: In Their Own Words
Owen Snider
Ottawa, ON
Camille Leahy
Toronto, ON
Ed Williams
Russell, Ontario
Researchers and Patients: A Shared Success
Find opportunities to get involved
Your healthcare team can help you find a cancer clinical trial in Canada and you can consult provincial and national resources like the Canadian Cancer Clinical Trials Group (CCTG).
Canadian Cancer Trials Group – CCTG
The CCTG supports phase I-III cancer clinical research trials in Canada and internationally. Visit the CCTG website to learn more about current CCTG trials.
BioCanRx funded Clinical Trials
Increasing the number of cancer immunotherapy clinical trials in Canada is at the core of our mission. Learn more about the clinical trials we have funded and the researchers behind them.
Cancer Trials Canada
A simple way to search and explore cancer clinical trials in Canada, with clear information to help patients and families understand their options.
The BioCanRx Cancer Community Partnership (CCP)
Patient & Caregiver Support
Find trusted organizations offering guidance, emotional support, and resources for those affected by cancer.
Education & Advocacy
Explore programs that raise awareness, share knowledge, and strengthen community involvement in cancer care.
Connecting Through Education
The BioCanRx-Cancer Community Partnership Learning Institute brings together leaders from oncology patient communities and academic scholars from the immunotherapy research community to engage in interactive and collaborative knowledge exchange activities at the annual Summit for Cancer Immunotherapy.